SENSEX NIFTY

Fda

Nov 21, 2014 at 11:33 | Source: Moneycontrol.com
The brokerage says Cipla aims to grow its sales from USD 1.6 billion to USD 5 billion by FY20 (21 percent compounded annual growth rate - CAGR).
Nov 18, 2014 at 14:55 | Source: Reuters
In the suit filed in the District Court for the District of Columbia, Ranbaxy said the FDA's move violated constitutional rights, exceeded the agency's statutory authority, and was "arbitrary, capricious, and otherwise contrary to law."
Nov 12, 2014 at 12:42 | Source: Reuters
Cadila Pharmaceuticals is the latest Indian drugmaker to face US regulatory rebuke, as the FDA intensifies its scrutiny of the generic drugmakers.
Nov 12, 2014 at 08:34 | Source: Reuters
India's USD 15 billion pharmaceutical industry, which has been hit by a spate of regulatory sanctions in the past year due to concerns about production processes, supplies about 40 percent of generic and over-the-counter drugs to the United States.
Nov 10, 2014 at 12:16 | Source: CNBC-TV18
For the largecap pharma companies the game has become completely US-cued. So, US will be the driver for Dr Reddys and Lupin, says Anmol Ganjoo.
Nov 10, 2014 at 11:10 | Source: Moneycontrol.com
Taro's gross profit, as a percentage of net sales, was at 79 percent compared to 77.7 percent. During the quarter, operating income increased USD 40.0 million to USD 160.3 million, or 63.9 percent of net sales, compared to 58.6 percent of net sales.
Nov 07, 2014 at 11:21 | Source: Reuters
The US Food and Drug Administration (FDA) said it has granted final approval to Indian drugmaker Dr Reddy's Laboratories and US firm Endo International Plc to make cheaper copies of Roche Holding AG's antiviral Valcyte.
Nov 07, 2014 at 10:14 | Source: CNBC-TV18
Ranbaxy has first-to-file status, meaning eligibility for six months of generic sales exclusivity for both AstraZeneca's heartburn drug Nexium & Roche's antiviral drug Valcyte drugs. However, the final approvals for these drugs were delayed because of the compliance issues at Ranbaxy's plants.
Nov 06, 2014 at 20:13 | Source: PTI
FDA has rescinded the previously granted tentative approvals for Ranbaxy's ANDAs for esomeprazole magnesium delayed-release capsules, 20 mg and 40 mg and for valganciclovir hydrochloride tablets USP, 450 mg, Ranbaxy Laboratories said.
Nov 05, 2014 at 12:45 | Source: CNBC-TV18
Arvind Bothra of Religare Capital Markets doesn't see US FDA action against Ipca translating into a similar action by European or other regulators because they have definitely different norms etc.
Messages on Fda »

BSE/NSE Announcer

Platinum Member

5263 Followers

Glenmark  

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th

BSE/NSE Announcer

Platinum Member

5263 Followers

Glenmark  

the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th

BSE/NSE Announcer

Platinum Member

5263 Followers

Shasun Pharma  

Shasun Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 08, 2014, titled "Sucessful completion of US FDA and Mexican COFEPRIS inspection".

11.41 AM Jul 8th

BSE/NSE Announcer

Platinum Member

5263 Followers

Shasun Pharma  

Shasun Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014, titled "Successful completion of US FDA and Mexican COFEPRIS inspection"

11.30 AM Jul 8th

hemal85

Silver Member

13 Followers

ITC  

how FDA (food & drug authority) is related with Mr. Modi?? & if u mean FDI....how will that make any difference to HUL or ITC??? kuchh bhi....

6.55 PM Jul 7th

teeyen

Silver Member

2 Followers

Natco Pharma  

Natco is an excellent stock with good prospects. However think of following before buying now. 1)Teva has filed a citizen petition before FDA which may delay copaxone generic approval by about 5-6 months 2) Teva has filed a petition in delhi high court for stopping production and export

6.38 PM Jul 7th

AlphaView

Gold Member

125 Followers

Granules India  

talking this even after discounting for risks such as FDA approvals et al.

6.13 PM Jul 7th

niftynewbie

Platinum Member

241 Followers

Ranbaxy Labs  

Spoiler could be sunpharma`s plants getting red-flagged by FDA ;)

5.10 PM Jul 7th

Sharon Bio Medicine  

Profit to fo up 3 fold! US FDA approval to come next qrtr!

3.22 PM Jul 7th

shivamparik
h

Platinum Member

43 Followers

ITC  

HUL doesnt deal in Cigarettes and FDA will be welcome by Mr. Modi. ITC may get benefits of Tourism ... HUL still wins out with a higher chance of UL bidding for complete or more control through buy out of shares. ITC will have issues with Govt. regulations in my opinion.

1.18 PM Jul 7th

News across the web »
Nov 17, 2014 at 10:17 | Source: Calcutta Telegraph News
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.